Interferon-alpha, immune activation and immune dysfunction in treated HIV infection
about
Immune Activation Influences SAMHD1 Expression and Vpx-mediated SAMHD1 Degradation during Chronic HIV-1 InfectionRole of the immune system in HIV-associated neuroinflammation and neurocognitive implications.New insights into type I interferon and the immunopathogenesis of persistent viral infections.HIV-1 Env and Nef Cooperatively Contribute to Plasmacytoid Dendritic Cell Activation via CD4-Dependent MechanismsDysregulated Immune Activation in Second-Line HAART HIV+ Patients Is Similar to That of Untreated Patients.Integrative Analysis of Immunological Data to Explore Chronic Immune T-Cell Activation in Successfully Treated HIV Patients.APOBEC3 proteins can copackage and comutate HIV-1 genomes.HIV Maintains an Evolving and Dispersed Population in Multiple Tissues during Suppressive Combined Antiretroviral Therapy in Individuals with Cancer.HIV-TB co-infection: mechanisms that drive reactivation of Mycobacterium tuberculosis in HIV infection.Immune Response and Mortality Risk Relate to Distinct Lung Microbiomes in Patients with HIV and Pneumonia.Δ9-Tetrahydrocannabinol Suppresses Secretion of IFNα by Plasmacytoid Dendritic Cells From Healthy and HIV-Infected Individuals.Greater decline in memory and global neurocognitive function in HIV/hepatitis C co-infected than in hepatitis C mono-infected patients treated with pegylated interferon and ribavirin.Interferon Alpha Subtype-Specific Suppression of HIV-1 Infection In Vivo.Immune activated monocyte exosomes alter microRNAs in brain endothelial cells and initiate an inflammatory response through the TLR4/MyD88 pathway.Control of HIV infection by IFN-α: implications for latency and a cure.HIV-infected cannabis users have lower circulating CD16+ monocytes and IP-10 levels compared to non-using HIV patients.Sustained IFN-I Expression during Established Persistent Viral Infection: A "Bad Seed" for Protective Immunity.Antiretroviral Drugs Alter the Content of Extracellular Vesicles from HIV-1-Infected Cells.Induction of Type I Interferons by Therapeutic Nanoparticle-Based Vaccination Is Indispensable to Reinforce Cytotoxic CD8+ T Cell Responses During Chronic Retroviral Infection."Toll-free" pathways for production of type I interferons
P2860
Q28589591-0C745DBF-0108-4DAF-A2E0-C19F05F870DFQ35125996-282FF810-F228-4285-B411-72953B151185Q35648751-AD1609F2-7A29-4E35-A706-7C8F9F05920FQ35861175-F9796596-918A-408E-B00D-F62C2A0D37FEQ35873402-54A8DED9-E3C9-47A6-A039-589DD10C3023Q36238363-E84DD864-0784-40DB-AFC5-E868B5769BB3Q37264399-9EEC0622-64AB-4FC3-A711-BB947D297905Q37300442-02CAB966-4DDB-4743-A7F1-72976677173CQ38816188-D79FB9D1-B433-48E2-9B86-0B14EC36A92BQ38853678-3CFFE7D2-C382-4632-A398-8C6630662ED5Q40129268-673F00C3-568B-4AFE-B30E-6143B20D4746Q40431770-73045F5B-096F-4097-9EE2-24D9144C544DQ40705563-920F7A4D-F0A4-471D-9D8B-A064A3EEC6C1Q41564855-27BD2BF5-9C62-4F89-A646-BAB9FCEC3F6BQ41922021-82DB5AFF-5654-4298-9356-1CA108D53BFFQ47342684-82C5823A-AAF9-42B0-BFC3-822AE0438DCAQ47558114-60026111-3E11-46F0-9F98-629729107195Q54209535-76C90AF0-4097-4649-864F-C51B93D810A7Q54217623-5120FB7B-34BA-47E7-8FF1-4BF3E0725985Q57018017-18EDB422-549C-4272-9D89-CA17E9C4F996
P2860
Interferon-alpha, immune activation and immune dysfunction in treated HIV infection
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Interferon-alpha, immune activation and immune dysfunction in treated HIV infection
@ast
Interferon-alpha, immune activation and immune dysfunction in treated HIV infection
@en
Interferon-alpha, immune activation and immune dysfunction in treated HIV infection
@nl
type
label
Interferon-alpha, immune activation and immune dysfunction in treated HIV infection
@ast
Interferon-alpha, immune activation and immune dysfunction in treated HIV infection
@en
Interferon-alpha, immune activation and immune dysfunction in treated HIV infection
@nl
prefLabel
Interferon-alpha, immune activation and immune dysfunction in treated HIV infection
@ast
Interferon-alpha, immune activation and immune dysfunction in treated HIV infection
@en
Interferon-alpha, immune activation and immune dysfunction in treated HIV infection
@nl
P2093
P2860
P3181
P356
P1476
Interferon-alpha, immune activation and immune dysfunction in treated HIV infection
@en
P2093
Allison Castley
Cassandra M Berry
David Nolan
Lilian Cha
P2860
P3181
P356
10.1038/CTI.2014.1
P407
P577
2014-02-01T00:00:00Z